高级检索
当前位置: 首页 > 详情页

Clinicopathologic and prognostic significance of CMTM6 and PD-L1 expression in cervical squamous cell carcinoma

| 认领 | 导出 |

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ ESCI

机构: [1]Capital Med Univ, Beijing Tongren Hosp, Dept Pathol, Key Lab Head & Neck Mol Diag Pathol, Beijing 100730, Peoples R China [2]Cangzhou Peoples Hosp, Dept Pathol, Cangzhou 061000, Hebei, Peoples R China
出处:
ISSN:

关键词: CMTM6 PD-L1 cervical squamous cell carcinoma metastasis prognosis

摘要:
It has been demonstrated that interfering with the expression of chemokine-like factor-like MARVEL transmembrane domain-containing family member 6 (CMTM6) results in impaired programmed death 1 ligand 1 (PD-L1) protein expression in human tumor cells. PD-L1 relies on CMTM6 to inhibit T cell responses and promote tumor cell proliferation. The aim of the present study was to investigate the expression of CMTM6 and PD-L1 in cervical cancer and their clinical significance. Immunohistochemistry was used to detect the expression of CMTM6 and PD-L1 in 50 normal cervical tissues and 102 cervical cancer tissue samples. The results showed that CMTM6 and PD-L1 expression was associated with clinical staging, lymph node metastasis, distant metastasis, and tumor differentiation. In addition, there was a positive association between the expression of CMTM6 and that of PD-L1 in cervical cancer tissue. Survival analysis results showed that high expression of CMTM6 and PD-L1 was positively correlated with poor prognosis in patients. Univariate analysis showed that lymph node metastasis was associated with the prognosis of cervical cancer patients. Cox analysis indicated that PD-L1 is a risk factor affecting the survival time of cervical cancer patients. In conclusion, the expression of CMTM6 and PD-L1 is elevated in cervical cancer tissue and closely related to poor prognosis. Therefore, CMTM6 and PD-L1 may be new molecular targets for the treatment of cervical cancer.

基金:
语种:
被引次数:
WOS:
PubmedID:
JCR分区:
出版当年[2021]版:
最新[2023]版:
Q3 PATHOLOGY Q4 ONCOLOGY Q4 PATHOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2021版] 出版当年五年平均 出版前一年[2020版] 出版后一年[2022版]

第一作者:
第一作者机构: [1]Capital Med Univ, Beijing Tongren Hosp, Dept Pathol, Key Lab Head & Neck Mol Diag Pathol, Beijing 100730, Peoples R China [2]Cangzhou Peoples Hosp, Dept Pathol, Cangzhou 061000, Hebei, Peoples R China
通讯作者:
通讯机构: [1]Capital Med Univ, Beijing Tongren Hosp, Dept Pathol, Key Lab Head & Neck Mol Diag Pathol, Beijing 100730, Peoples R China [2]Cangzhou Peoples Hosp, Dept Pathol, Cangzhou 061000, Hebei, Peoples R China [*1]De-partment of Pathology, Cangzhou People’s Hos-pital, Cangzhou 061000, Hebei, P. R. China [*2]Department of Pathology, Key Laboratory of Head and Neck Molecular Diagnosis Pathology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, P. R. China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:21169 今日访问量:0 总访问量:1219 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)